Education
About Us
Working with TipRanks
Follow Us
Phathom Pharmaceuticals (PHAT)
NASDAQ:PHAT
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 175.11M | $ 55.25M | $ 682.00K | $ 0.00 | $ 0.00 |
| Gross Profit | $ 152.51M | $ 47.28M | $ 515.00K | $ -620.00K | $ -521.00K |
| Operating Income | $ -159.99M | $ -277.47M | $ -167.31M | $ -172.44M | $ -135.08M |
| EBITDA | $ 633.00K | $ -261.52M | $ -159.05M | $ -169.80M | $ -136.57M |
| Net Income | $ 0.00 | $ -334.33M | $ -201.59M | $ -197.72M | $ -143.88M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 129.97M | $ 297.26M | $ 381.39M | $ 155.38M | $ 183.26M |
| Total Assets | $ 259.15M | $ 378.32M | $ 413.84M | $ 164.81M | $ 189.43M |
| Total Debt | $ 2.71M | $ 554.95M | $ 139.03M | $ 97.07M | $ 91.34M |
| Net Debt | $ -127.26M | $ 257.68M | $ -242.36M | $ -58.31M | $ -91.92M |
| Total Liabilities | $ 697.32M | $ 631.90M | $ 486.60M | $ 239.62M | $ 117.28M |
| Stockholders' Equity | $ -438.17M | $ -253.58M | $ -72.76M | $ -74.81M | $ 72.16M |
| Cash Flow | |||||
| Free Cash Flow | $ -166.78M | $ -266.90M | $ -139.21M | $ -147.57M | $ -148.78M |
| Operating Cash Flow | $ -166.78M | $ -266.77M | $ -137.58M | $ -146.53M | $ -148.46M |
| Investing Cash Flow | $ -229.00K | $ -135.00K | $ -1.63M | $ -1.04M | $ -328.00K |
| Financing Cash Flow | $ -288.00K | $ 182.77M | $ 367.58M | $ 120.04M | $ 44.71M |